Patents by Inventor James Halbrook

James Halbrook has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Materials and methods to potentiate cancer treatment
    Patent number: 8242115
    Abstract: Compounds that inhibit DNA-dependent protein kinase, compositions comprising the compounds, methods to inhibit the DNA-PK biological activity, methods to sensitize cells the agents that cause DNA lesions, and methods to potentiate cancer treatment are disclosed.
    Type: Grant
    Filed: February 16, 2007
    Date of Patent: August 14, 2012
    Assignee: Luitpold Pharmaceuticals, Inc.
    Inventors: James Halbrook, Edward A. Kesicki, Laurence E. Burgess, Stephen T. Schlachter, Charles T. Eary, Justin G. Schiro, Hongmei Huang, Michael Evans, Yongxin Han
  • Materials and methods to potentiate cancer treatment
    Publication number: 20080090782
    Abstract: Compounds that inhibit DNA-dependent protein kinase, compositions comprising the compounds, methods to inhibit the DNA-PK biological activity, methods to sensitize cells the agents that cause DNA lesions, and methods to potentiate cancer treatment are disclosed.
    Type: Application
    Filed: February 16, 2007
    Publication date: April 17, 2008
    Applicant: Luitpold Pharmaceuticals, Inc.
    Inventors: James Halbrook, Edward Kesicki, Laurence Burgess, Stephen Schlachter, Charles Eary, Justin Schiro, Hongmei Huang, Michael Evans, Yongxin Han
  • Xanthones, thioxanthones and acridinones as dna-pk inhibitors
    Publication number: 20070167441
    Abstract: Compound that inhibit DNA-dependent protein kinase, compositions comprising the compounds, methods of inhibiting the DNA-PK biological activity, methods of sensitizing cells the agents that cause DNA lesions, and methods of potentiating cancer treatment are disclosed.
    Type: Application
    Filed: March 19, 2004
    Publication date: July 19, 2007
    Inventors: James Halbrook, Edward Kesicki, Laurence Burgess, Stephen Schlachter, Charles Eary, Justin Schiro
  • Materials and methods to potentiate cancer treatment
    Patent number: 7179912
    Abstract: Compounds that inhibit DNA-dependent protein kinase, compositions comprising the compounds, methods to inhibit the DNA-PK biological activity, methods to sensitize cells the agents that cause DNA lesions, and methods to potentiate cancer treatment are disclosed.
    Type: Grant
    Filed: August 28, 2001
    Date of Patent: February 20, 2007
    Assignee: ICOS Corporation
    Inventors: James Halbrook, Edward A. Kesicki, Laurence E. Burgess, Stephen T. Schlachter, Charles T. Eary, Justin G. Schiro, Hongmei Huang, Michael Evans, Yongxin Han
  • Materials and methods to potentiate cancer treatment
    Publication number: 20020165218
    Abstract: Compounds that inhibit DNA-dependent protein kinase, compositions comprising the compounds, methods to inhibit the DNA-PK biological activity, methods to sensitize cells the agents that cause DNA lesions, and methods to potentiate cancer treatment are disclosed.
    Type: Application
    Filed: August 28, 2001
    Publication date: November 7, 2002
    Inventors: James Halbrook, Edward A. Kesicki, Laurence E. Burgess, Stephen T. Schlachter, Charles T. Eary, Justin G Schiro, Hongmei Huang, Michael Evans, Yongxin Han